Vibalogics has increased its single-use bioreactor and purification capacity with a new manufacturing for its specialist oncolytic virus and viral vector manufacturing services as a result of a growth in demand.
Supplier News
Advertisement
AbCellera, Niaid Vaccine Research Center, and Ichor Medical Systems have formed a partnership to develop an end-to-end platform capable of developing field-ready, nucleic acid-based countermeasures against a pandemic strain of influenza.
Lonza will provide development and manufacturing services to two of Alector’s neurodegeneration drug candidates.
Samsung BioLogics will provide contract development organization services to drug developer GI Innovation.
The Vaccine Development and Bioprocess Cell Culture Technology Day will take place on May 16, 2019 in Baltimore, MD.
In collaboration with Pall Corportion, biotech company Freeline completed the first full-scale run at its newly commissioned, GMP gene-therapy manufacturing facility in the UK.
The EXcell 231 and EXcell 241 sensors from EXNER Process Equipment have updated software and connection features for improved flexibility and safety.
Intertek has announced the expansion of its pharmaceutical services laboratory in Melbourn, near Cambridge, UK, through the acquisition of a new 20,000 sq. ft facility.
The company’s center of excellence for advanced analytical testing passed GMP inspection from the European Medicines Agency.
Contract packaging and clinical supply service company Sharp invested $21 million to expand its packaging capacity and capabilities in Pennsylvania.
Advertisement
Biocatalysts, a global biotechnology company, has announced it has been named as one of the winners of the Queen’s Awards for Enterprise in Innovation.
The expansion of the CDMO’s Skokie, IL facility includes additional refrigeration and freezer space.
The company passed a seven-day FDA surveillance GMP inspection and announced two upcoming manufacturing partnerships.
Novartis has announced that FDA has accepted its biologics license application (BLA) for brolucizumab (RTH258) for the treatment of wet age-related macular degeneration (AMD).
The companies will merge to offer a broader range of analytical data packages and regulatory support for biopharmaceuticals.
Catalent’s acquisition of Paragon Bioservices will provide expertise in expanding gene therapy market.
Legacy Pharmaceuticals has entered into a collaboration with SCHOTT to solve a technical challenge of leaching that is occurring with an antiviral drug.
The companies will join forces on a research project to develop end-to-end workflows for the preparation, characterization, and monitoring of biotherapeutics using liquid chromatography-mass spectrometry.
The new service offers a flexible, customizable suite of products and services designed to accelerate the clinical and commercial development of gene and cell therapies.
Concerto HealthAI’s real-world data and artificial intelligence capabilities are expected to accelerate outcomes studies and patient insights for Pfizer’s investigational therapies and commercialized therapeutics.
The company’s Quantum peristaltic pump uses a patented single-use cartridge technology and is applicable to downstream bioprocessing.
The companies form a strategic joint venture for developing and manufacturing live biotherapeutics.
The BioContinuum Buffer Delivery Platform offers streamlined buffer management and delivers “contiGuous” bioprocessing.
The Quartic Platform is a new, AI-powered smart manufacturing platform that can be integrated into legacy facilities and manufacturing processes.
ITT Engineered Valves presented its new EnviZion hygienic valve technology at INTERPHEX 2019 in New York City.
The Kimble GLS 80 Media Bottle and Multiport Cap System from DWK Life Sciences, showcased at INTERPHEX 2019 in New York City, is capable of performing a multitude of laboratory applications.
The partnership will enable the Applied Process Company (APC) and the National Institute for Bioprocessing Research & Training (NIBRT) to provide increased access to R&D and analytical services.
XenTech and the Gustave Roussy Cancer Center have signed a strategic collaboration agreement aimed at the development of a collection of tumor explant models from patients with acquired resistance to targeted therapies.
NJII and Pall collaborate to address biomanufacturing technology and workforce development challenges.
The GE Healthcare and Rockwell Automation collaboration will help meet the needs of the biopharma 4.0 era.
Advertisement
Advertisement
